发明名称 Methods and compounds for reducing intracellular lipid storage
摘要 Compounds and compositions for reducing intracellular lipid accumulation in a cell are described herein. These compounds are useful for the treatment and prevention of lipid/glycogen disorders, as well as for the treatment and prevention of obesity. A high throughput screen for identifying compounds that reduce intracellular lipid accumulation in cells is also provided.
申请公布号 US9393221(B2) 申请公布日期 2016.07.19
申请号 US201213552975 申请日期 2012.07.19
申请人 THE GENERAL HOSPITAL CORPORATION 发明人 Wu Sean
分类号 C12N5/00;C12N5/02;A61K31/137;A61K31/215;A61K31/4375;A61K31/439;A61K31/4458;A61K31/4709;A61K31/706;C40B30/06;G01N33/50;G01N33/92 主分类号 C12N5/00
代理机构 Nixon Peabody LLP 代理人 Nixon Peabody LLP
主权项 1. A method for reducing intracellular lipid accumulation in a cell comprising contacting the cell in vitro or in vivo with an effective amount of a compound selected from Table 3, wherein the effective amount of the compound shifts cellular energy metabolism from fatty acid oxidation to glycolysis, thereby reducing intracellular lipid accumulation within the cell, wherein the cell has reduced Adipose Triglyceride Lipase (ATGL) function due to a loss of function mutation in the gene PNPLA2.
地址 Boston MA US